214 related articles for article (PubMed ID: 2308989)
1. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M
Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989
[No Abstract] [Full Text] [Related]
2. Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.
Shimazaki C; Inaba T; Murakami S; Fujita N; Nakagawa M; Gulati SC; Fried J; Clarkson BD; Wisniewolski R; Wang CY
Prog Clin Biol Res; 1990; 333():311-9. PubMed ID: 2308988
[No Abstract] [Full Text] [Related]
3. Breast cancer and laser photoradiation therapy: an in vitro model for autologous bone marrow purging.
Gulliya KS; Batagllino M; Matthews JL
Prog Clin Biol Res; 1990; 333():103-7. PubMed ID: 2308975
[No Abstract] [Full Text] [Related]
4. Immunomagnetic manipulation of bone marrow and tumour cells: an update.
Kemshead JT; Elsom G; Patel K
Prog Clin Biol Res; 1990; 333():235-50; discussion 251. PubMed ID: 2408061
[TBL] [Abstract][Full Text] [Related]
5. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
[TBL] [Abstract][Full Text] [Related]
6. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
Alonso K; Medenica R; Morehead G
Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
[No Abstract] [Full Text] [Related]
7. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.
Shpall EJ; Bast RC; Joines WT; Jones RB; Anderson I; Johnston C; Eggleston S; Tepperberg M; Edwards S; Peters WP
Bone Marrow Transplant; 1991 Feb; 7(2):145-51. PubMed ID: 2049558
[TBL] [Abstract][Full Text] [Related]
8. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles.
Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757
[TBL] [Abstract][Full Text] [Related]
9. Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation.
Morecki S; Slavin S
Isr J Med Sci; 1988; 24(9-10):488-93. PubMed ID: 3060442
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation.
Kies MS; Gordon LI; Rosen ST; Kucuk O; Vriesendorp HM
Exp Hematol; 1988 Mar; 16(3):190-4. PubMed ID: 3276545
[TBL] [Abstract][Full Text] [Related]
11. In vitro active cyclophosphamide derivatives in cleansing procedures intended for autologous bone marrow transplantation.
Manna A; Sparaventi G; Palazzi M; Porcellini A
Haematologica; 1986; 71(3):257-61. PubMed ID: 3093332
[No Abstract] [Full Text] [Related]
12. Bone marrow purging with immunotoxins for treatment of T cell acute lymphoblastic leukemia (T-ALL).
Vallera DA; Uckun FM
Prog Clin Biol Res; 1990; 333():191-204; discussion 205. PubMed ID: 2308981
[No Abstract] [Full Text] [Related]
13. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
[TBL] [Abstract][Full Text] [Related]
14. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
[TBL] [Abstract][Full Text] [Related]
15. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres.
O'Briant KC; Shpall EJ; Houston LL; Peters WP; Bast RC
Cancer; 1991 Sep; 68(6):1272-8. PubMed ID: 1873781
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads.
Vredenburgh JJ; Simpson W; Memoli VA; Ball ED
Cancer Res; 1991 May; 51(9):2451-5. PubMed ID: 1673088
[TBL] [Abstract][Full Text] [Related]
17. Immunomagnetic microsphere mediated purging of cALLa positive leukemic cells from bone marrow for autologous reinfusion.
Janssen WE; Lee C; Johnson KS; Spencer C; Rios AM; Graham-Pole JR; Gross S
Prog Clin Biol Res; 1990; 333():285-92. PubMed ID: 2137931
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of colony growth and hematologic engraftment in patients undergoing high-dose chemotherapy and autologous bone marrow transplantation for breast cancer.
Meehan KR; Ericson SG; Tosteson TD; Mills LE
Prog Clin Biol Res; 1994; 389():497-503. PubMed ID: 7535459
[No Abstract] [Full Text] [Related]
19. 4-Hydroperoxycyclophosphamide treatment of stored bone marrow grafts.
Davis JM; Schepers KG; Noga SJ; Jones RJ
Prog Clin Biol Res; 1994; 389():3-7. PubMed ID: 7700912
[No Abstract] [Full Text] [Related]
20. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]